Drug intelligence / Profile preview

APPR

Development stage
Preclinical
Lead developer
Stowers Institute for Medical Research
Modality
mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Peptides
01

Overview

APPR (Artificial-intelligence-powered Peptide-Producing mRNAs) is an experimental mRNA-based therapeutic designed to target the Akt-Wnt/β-catenin signaling pathway. Developed by researchers at the Stowers Institute for Medical Research and collaborating institutions, APPR utilizes AI-optimized mRNA sequences to produce peptides that disrupt the interaction between Akt and β-catenin. Specifically, these peptides are designed to inhibit Akt-mediated phosphorylation of β-catenin at Ser552 and Ser675, thereby reducing its transcriptional activity and translocation to the nucleus. This mechanism aims to overcome immune escape and eliminate leukemia stem cells (LSCs) in cancers such as T-acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML). In preclinical studies, APPR has demonstrated the ability to reduce Wnt-responsive gene expression and decrease LSC populations in mouse models without significant tissue damage.

Other names
Artificial-intelligence-powered Peptide-Producing mRNAs

Beyond the preview

Go deeper on APPR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APPR.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call